asm8
Nucleic acidexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2005 (NCT00264966)
Timeline
Indications
Studied for
Mechanism of action
- C-C chemokine receptor type 3ANTISENSE INHIBITOR
CCR3 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asm8
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01380236 | Phase 2 | Nov 1, 2011 | Syntara |
| NCT00402948 | Phase 2 | Feb 1, 2007 | Firestone Institute for Respiratory Health, Syntara |
| NCT00264966 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2005 | McMaster University, Syntara |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Syntara | For profit | 3 | 3 | 1 | 2005 |
| Firestone Institute for Respiratory Health | Academic/Hospital | 1 | 0 | 1 | 2007 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2005 |
3 organizations
Page 1 / 1